Compare Cigna Corp (CI) vs YieldMax NVDA Option Income Strategy ETF (NVDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs YieldMax NVDA Option Income Strategy ETF — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while YieldMax NVDA Option Income Strategy ETF trades at $12.79. The key difference: Cigna Corp pays a 2.24% dividend while YieldMax NVDA Option Income Strategy ETF pays none, and Cigna Corp is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| CI | NVDY | |
|---|---|---|
Market Cap | $73.56B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $311.00 | $17.96 |
52-Week Low | $244.41 | $11.58 |
Enterprise Value | $98.27B | — |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
NVDY trades at $13.00, up 1.72% with a bullish technical signal from moving averages. The ETF generates weekly dividend distributions ranging from $0.09 to $0.15, providing consistent income. Recent news highlights the fund's strategy of selling NVIDIA call options to fund distributions while potentially capping upside. Technical indicators show mixed signals with RSI at extreme levels suggesting potential overbought conditions.
The outlook balances income generation against opportunity cost. While weekly distributions offer attractive yield, the strategy may limit participation in NVIDIA's full growth potential. Key risks include the fund's dependence on NVIDIA's volatility and the trade-off between income and capital appreciation. Investors seeking regular income may find value, but those prioritizing growth might prefer direct NVIDIA exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →
